GGrantIndex
← Leaderboards

David A Mankoff

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗
$17,196,499
Attributed
$24,654,199
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,654,199 · 17

By mechanism

R01$13,106,969 · 6
P30$2,666,533 · 3
P01$2,253,156 · 3
T32$2,147,617 · 1
U01$1,737,668 · 1
R33$1,448,329 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsPositron-Emission TomographyResponseClinical TrialsImageProgramsResearch PersonnelClinical ResearchTumorImaging ModalityLeadFundingProtocols DocumentationMethodologyImaging BiomarkerFutureMolecular ImagingBaseImage AnalysisMalignant Breast NeoplasmIn VivoTranslational ResearchUptakeMetabolism

Grant awards (79)

Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$538,647
R01 · FY2025 · CA · contact PI
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$522,750
R01 · FY2025 · CA · contact PI
Research Track Radiology Residency$350,920
T32 · FY2025 · EB · contact PI
Cancer Research Training and Education Coordination$186,620
P30 · FY2025 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$538,137
R01 · FY2024 · CA · contact PI
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$496,614
R01 · FY2024 · CA · contact PI
Research Track Radiology Residency$262,962
T32 · FY2024 · EB · contact PI
Cancer Research Training and Education Coordination$186,636
P30 · FY2024 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$597,988
R01 · FY2023 · CA · contact PI
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$517,072
R01 · FY2023 · CA · contact PI
Research Track Radiology Residency$241,409
T32 · FY2023 · EB · contact PI
Cancer Research Training and Education Coordination$182,703
P30 · FY2023 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$601,217
R01 · FY2022 · CA · contact PI
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$562,902
R01 · FY2022 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2022 · CA
Research Track Radiology Residency$206,923
T32 · FY2022 · EB · contact PI
Cancer Research Training and Education Coordination$179,625
P30 · FY2022 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$631,080
R01 · FY2021 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$402,259
R01 · FY2021 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$338,745
UE5 · FY2021 · CA
Research Track Radiology Residency$246,644
T32 · FY2021 · EB · contact PI
Cancer Research Training and Education Coordination$174,293
P30 · FY2021 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$402,259
R01 · FY2020 · CA · contact PI
Cancer Imaging Core$361,216
P30 · FY2020 · CA · contact PI
The cell and gene therapy toolkit for junior faculty$319,685
UE5 · FY2020 · CA
Research Track Radiology Residency$230,531
T32 · FY2020 · EB · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$390,191
R01 · FY2019 · CA · contact PI
Cancer Imaging Core$361,563
P30 · FY2019 · CA · contact PI
RESEARCH TRACK RADIOLOGY RESIDENCY$210,587
T32 · FY2019 · EB · contact PI
Cancer Imaging Core$7,211
P30 · FY2019 · CA · contact PI
Cancer Imaging Core$5,767
P30 · FY2019 · CA · contact PI
Cancer Imaging Core$3,626
P30 · FY2019 · CA · contact PI
Cancer Imaging Core$1,106
P30 · FY2019 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$382,319
R01 · FY2018 · CA · contact PI
Cancer Imaging Core$321,901
P30 · FY2018 · CA · contact PI
RESEARCH TRACK RADIOLOGY RESIDENCY$198,088
T32 · FY2018 · EB · contact PI
Cancer Imaging Core$9,405
P30 · FY2018 · CA · contact PI
Cancer Imaging Core$2,508
P30 · FY2018 · CA · contact PI
Cancer Imaging Core$2,143
P30 · FY2018 · CA · contact PI
Area B: Multi-Tracer Volumetric PET (MTV-PET) to Measure Tumor Glutamine and Glucose Metabolic Rates in a Single Imaging Session$1,448,329
R33 · FY2017 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$414,966
R01 · FY2017 · CA · contact PI
Cancer Imaging Core$340,600
P30 · FY2017 · CA · contact PI
RESEARCH TRACK RADIOLOGY RESIDENCY$199,553
T32 · FY2017 · EB · contact PI
Cancer Imaging Core$339,610
P30 · FY2016 · CA · contact PI
Imaging Therapeutic Targets$196,998
P01 · FY2015 · CA · contact PI
Data Analysis$151,866
P01 · FY2015 · CA · contact PI
Imaging Therapeutic Targets$192,822
P01 · FY2014 · CA · contact PI
Data Analysis$146,962
P01 · FY2014 · CA · contact PI
Imaging Therapeutic Targets$189,030
P01 · FY2013 · CA · contact PI
Data Analysis$142,444
P01 · FY2013 · CA · contact PI
Advanced PET/CT Imaging for Improving Clincail Trials$562,213
U01 · FY2012 · CA
Imaging Therapeutic Targets$202,892
P01 · FY2012 · CA · contact PI
Data Analysis$151,120
P01 · FY2012 · CA · contact PI
Advanced PET/CT Imaging for Improving Clincail Trials$565,840
U01 · FY2011 · CA
Advanced PET/CT Imaging for Improving Clincail Trials$609,615
U01 · FY2010 · CA
PET to Measure Breast Cancer Bone Metastasis Response$372,777
R01 · FY2010 · CA · contact PI
PET to Measure Breast Cancer Bone Metastasis Response$364,744
R01 · FY2009 · CA · contact PI
PET to Measure Breast Cancer Bone Metastasis Response$359,666
R01 · FY2008 · CA · contact PI
Estrogen Receptor Positive Breast Cancer and its Response to Therapy$148,380
P01 · FY2008 · CA · contact PI
PET to Measure Breast Cancer Bone Metastasis Response$362,448
R01 · FY2007 · CA · contact PI
Estrogen Receptor Positive Breast Cancer and its Response to Therapy$148,450
P01 · FY2007 · CA · contact PI
Imaging the Response of Locally Advanced Breast Cancer$574,810
R01 · FY2006 · CA · contact PI
Estrogen Receptor Positive Breast Cancer and Therapy$103,284
P01 · FY2006 · CA · contact PI
Imaging the Response of Locally Advanced Breast Cancer$574,335
R01 · FY2005 · CA
Estrogen Receptor Positive Breast Cancer and Therapy$100,519
P01 · FY2005 · CA
Imaging the Response of Locally Advanced Breast Cancer$560,449
R01 · FY2004 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer$410,558
R01 · FY2004 · CA
Estrogen Receptor Positive Breast Cancer and Therapy$97,591
P01 · FY2004 · CA
Imaging the Response of Locally Advanced Breast Cancer$546,573
R01 · FY2003 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer$398,602
R01 · FY2003 · CA
Imaging the Response of Locally Advanced Breast Cancer$531,003
R01 · FY2002 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer$386,990
R01 · FY2002 · CA
IMAGING FOR EVALUATION OF CLINICAL VACCINE EFFICACY$296,752
U54 · FY2002 · CA
PET IMAGING OF ESTROGEN RECEPTORS IN BREAST CANCER$0
P01 · FY2002 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer$392,841
R01 · FY2001 · CA
IMAGING FOR EVALUATION OF CLINICAL VACCINE EFFICACY$0
U54 · FY2001 · CA
PET IMAGING OF ESTROGEN RECEPTORS IN BREAST CANCER$0
P01 · FY2001 · CA
PET IMAGING OF ESTROGEN RECEPTORS IN BREAST CANCER$280,798
P01 · FY2000 · CA
IMAGING THE RESPONSE OF LOCALLY ADVANCED BREAST CANCER$272,772
R01 · FY2000 · CA